Cargando…

High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine

BACKGROUND: Curaçao is a Dutch-Caribbean Island located in a high-risk area for cervical cancer. Prior to introduction of a prophylactic human papillomavirus (HPV) vaccine, knowledge of the prevalence of high-risk HPV vaccine genotypes (HPV16, 18, 31, 33, 45, 52 and 58) in cervical (pre)cancer is re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hooi, Desiree J, Lissenberg-Witte, Birgit I, de Koning, Maurits N C, Pinedo, Herbert M, Kenter, Gemma G, Meijer, Chris JLM, Quint, Wim G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969325/ https://www.ncbi.nlm.nih.gov/pubmed/29021405 http://dx.doi.org/10.1136/sextrans-2017-053109

Ejemplares similares

Human papillomavirus (HPV) types prevalence in cervical samples of female sex-workers on Curaçao
por: Hooi, Desiree J., et al.
Publicado: (2018)

Human papillomavirus (HPV) prevalence and associated risk factors in women from Curaçao
por: Hooi, Desiree J., et al.
Publicado: (2018)

Supravaginal hysterectomy in Curaçao prevalence and impact on screening for cervical cancer
por: Hooi, Desiree J., et al.
Publicado: (2017)

FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years
por: Vink, Frederique J, et al.
Publicado: (2022)

Whole tissue cervical mapping of HPV infection: Molecular evidence for focal latent HPV infection in humans
por: Hammer, Anne, et al.
Publicado: (2019)

Explanations for the high potency of HPV prophylactic vaccines
por: Schiller, John, et al.
Publicado: (2018)

Risk-stratification of HPV-positive women with low-grade cytology by FAM19A4/miR124-2 methylation and HPV genotyping
por: Dick, Stèfanie, et al.
Publicado: (2021)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

High prevalence of HPV16 and high‐grade cytology in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2
por: Damgaard, Rikke Kamp, et al.
Publicado: (2023)

Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria
por: Modibbo, Fatima, et al.
Publicado: (2017)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
por: Hampson, Ian N.
Publicado: (2022)

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening
por: Coupé, V M H, et al.
Publicado: (2008)

HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia
por: Bierkens, Mariska, et al.
Publicado: (2012)

Immortalization capacity of HPV types is inversely related to chromosomal instability
por: Schütze, Denise M., et al.
Publicado: (2016)

Cervical cancer risk in HPV‐positive women after a negative FAM19A4/mir124‐2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow‐up
por: De Strooper, Lise M.A., et al.
Publicado: (2018)

Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development
por: Pinto, Ligia A., et al.
Publicado: (2018)

The Effect of Prophylactic HPV Vaccines on Oral and Oropharyngeal HPV Infection—A Systematic Review
por: Nielsen, Kristoffer Juul, et al.
Publicado: (2021)

Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology‐screened referral population
por: Leeman, Annemiek, et al.
Publicado: (2018)

Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer
por: Scholten, Kirsten BJ, et al.
Publicado: (2011)

Evidence of latent HPV infection in older Danish women with a previous history of cervical dysplasia
por: Hammer, Anne, et al.
Publicado: (2022)

Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: A case-control study in Uganda
por: de Koning, Maurits NC, et al.
Publicado: (2008)

Sound efficacy of prophylactic HPV vaccination: Basics and implications
por: Lehtinen, Matti, et al.
Publicado: (2012)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
por: Mo, Yicheng, et al.
Publicado: (2022)

Prevalence of HPV infection and other risk factors in a Fijian population
por: Foliaki, Sunia, et al.
Publicado: (2014)

Prophylactic HPV vaccines: prospects for eliminating ano-genital cancer
por: Stanley, M
Publicado: (2007)

HPV Prophylactic Vaccination in Males Improves the Clearance of Semen Infection()
por: Foresta, Carlo, et al.
Publicado: (2015)

Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means
por: Carse, Sinead, et al.
Publicado: (2021)

HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV
por: Kremer, Wieke W., et al.
Publicado: (2018)

HPV Serology Testing Confirms High HPV Immunisation Coverage in England
por: Mesher, David, et al.
Publicado: (2016)

High Prevalence of HPV 51 in an Unvaccinated Population and Implications for HPV Vaccines
por: Bowden, Sarah J., et al.
Publicado: (2022)

Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening
por: Verhoef, Lisanne, et al.
Publicado: (2023)

Alterations of HPV-Related Biomarkers after Prophylactic HPV Vaccination. A Prospective Pilot Observational Study in Greek Women
por: Valasoulis, George, et al.
Publicado: (2020)

hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis
por: de Wilde, Jillian, et al.
Publicado: (2010)

Six-Month Incidence and Persistence of Oral HPV Infection in HIV-Negative and HIV-Infected Men Who Have Sex with Men
por: Mooij, Sofie H., et al.
Publicado: (2014)

Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
por: Rafael, Tynisha S., et al.
Publicado: (2022)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
por: van Poelgeest, Mariette I E, et al.
Publicado: (2013)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

HPV Detection Methods
por: Brink, Antoinette A. T. P., et al.
Publicado: (2007)

Grading immunohistochemical markers p16(INK4a) and HPV E4 identifies productive and transforming lesions caused by low‐ and high‐risk HPV within high‐grade anal squamous intraepithelial lesions
por: Leeman, A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5spnr6peu4mgkci8q5l4fntl0i